<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-12-01" modified="2020-10-07" version="207">
<accession>Q92673</accession>
<accession>B2RNX7</accession>
<accession>Q92856</accession>
<name>SORL_HUMAN</name>
<protein>
<recommendedName>
<fullName>Sortilin-related receptor</fullName>
</recommendedName>
<alternativeName>
<fullName>Low-density lipoprotein receptor relative with 11 ligand-binding repeats</fullName>
<shortName>LDLR relative with 11 ligand-binding repeats</shortName>
<shortName evidence="51">LR11</shortName>
</alternativeName>
<alternativeName>
<fullName evidence="53">SorLA-1</fullName>
</alternativeName>
<alternativeName>
<fullName>Sorting protein-related receptor containing LDLR class A repeats</fullName>
<shortName evidence="52">SorLA</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SORL1</name>
<name type="synonym">C11orf32</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="Arterioscler. Thromb. Vasc. Biol." volume="17" first="996" last="1002">
<title>A novel mosaic protein containing LDL receptor elements is highly conserved in humans and chickens.</title>
<authorList>
<person name="Morwald S."/>
<person name="Yamazaki H."/>
<person name="Bujo H."/>
<person name="Kusunoki J."/>
<person name="Kanaki T."/>
<person name="Seimiya K."/>
<person name="Morisaki N."/>
<person name="Nimpf J."/>
<person name="Schneider W.J."/>
<person name="Saito Y."/>
</authorList>
<dbReference type="PubMed" id="9157966"/>
<dbReference type="DOI" id="10.1161/01.atv.17.5.996"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS GLU-1074 AND ILE-1967</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="31379" last="31383">
<title>Molecular characterization of a novel human hybrid-type receptor that binds the alpha2-macroglobulin receptor-associated protein.</title>
<authorList>
<person name="Jacobsen L."/>
<person name="Madsen P."/>
<person name="Moestrup S.K."/>
<person name="Lund A.H."/>
<person name="Tommerup N."/>
<person name="Nykjaer A."/>
<person name="Sottrup-Jensen L."/>
<person name="Gliemann J."/>
<person name="Petersen C.M."/>
</authorList>
<dbReference type="PubMed" id="8940146"/>
<dbReference type="DOI" id="10.1074/jbc.271.49.31379"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PROTEIN SEQUENCE OF 82-91; 114-121; 405-415 AND 2019-2030</scope>
<scope>VARIANTS GLU-1074 AND ILE-1967</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH LRPAP1</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="440" first="497" last="500">
<title>Human chromosome 11 DNA sequence and analysis including novel gene identification.</title>
<authorList>
<person name="Taylor T.D."/>
<person name="Noguchi H."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Kuroki Y."/>
<person name="Dewar K."/>
<person name="Lloyd C."/>
<person name="Itoh T."/>
<person name="Takeda T."/>
<person name="Kim D.-W."/>
<person name="She X."/>
<person name="Barlow K.F."/>
<person name="Bloom T."/>
<person name="Bruford E."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Eichler E."/>
<person name="FitzGerald M.G."/>
<person name="Jaffe D.B."/>
<person name="LaButti K."/>
<person name="Nicol R."/>
<person name="Park H.-S."/>
<person name="Seaman C."/>
<person name="Sougnez C."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Zody M.C."/>
<person name="Birren B.W."/>
<person name="Nusbaum C."/>
<person name="Fujiyama A."/>
<person name="Hattori M."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Sakaki Y."/>
</authorList>
<dbReference type="PubMed" id="16554811"/>
<dbReference type="DOI" id="10.1038/nature04632"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANTS GLU-1074 AND ILE-1967</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANTS GLU-1074 AND ILE-1967</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="J. Cell Sci." volume="113" first="4475" last="4485">
<title>Ectodomain shedding, translocation and synthesis of SorLA are stimulated by its ligand head activator.</title>
<authorList>
<person name="Hampe W."/>
<person name="Riedel I.B."/>
<person name="Lintzel J."/>
<person name="Bader C.O."/>
<person name="Franke I."/>
<person name="Schaller H.C."/>
</authorList>
<dbReference type="PubMed" id="11082041"/>
</citation>
<scope>INTERACTION WITH HA</scope>
<scope>INDUCTION BY HA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CLEAVAGE OF THE PROPEPTIDE</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="22788" last="22796">
<title>Activation and functional characterization of the mosaic receptor SorLA/LR11.</title>
<authorList>
<person name="Jacobsen L."/>
<person name="Madsen P."/>
<person name="Jacobsen C."/>
<person name="Nielsen M.S."/>
<person name="Gliemann J."/>
<person name="Petersen C.M."/>
</authorList>
<dbReference type="PubMed" id="11294867"/>
<dbReference type="DOI" id="10.1074/jbc.m100857200"/>
</citation>
<scope>PROTEIN SEQUENCE OF 82-86</scope>
<scope>CLEAVAGE OF THE PROPEPTIDE</scope>
<scope>INTERACTION WITH HA; LRPAP1; NTS AND PROPEPTIDE</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION</scope>
<scope>MUTAGENESIS OF 78-ARG--ARG-81</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Biol. Chem." volume="383" first="1727" last="1733">
<title>Characterization of the VPS10 domain of SorLA/LR11 as binding site for the neuropeptide HA.</title>
<authorList>
<person name="Lintzel J."/>
<person name="Franke I."/>
<person name="Riedel I.B."/>
<person name="Schaller H.C."/>
<person name="Hampe W."/>
</authorList>
<dbReference type="PubMed" id="12530537"/>
<dbReference type="DOI" id="10.1515/bc.2002.193"/>
</citation>
<scope>INTERACTION WITH HA; LRPAP1 AND PROPEPTIDE</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="FEBS Lett." volume="511" first="155" last="158">
<title>The sorLA cytoplasmic domain interacts with GGA1 and -2 and defines minimum requirements for GGA binding.</title>
<authorList>
<person name="Jacobsen L."/>
<person name="Madsen P."/>
<person name="Nielsen M.S."/>
<person name="Geraerts W.P.M."/>
<person name="Gliemann J."/>
<person name="Smit A.B."/>
<person name="Petersen C.M."/>
</authorList>
<dbReference type="PubMed" id="11821067"/>
<dbReference type="DOI" id="10.1016/s0014-5793(01)03299-9"/>
</citation>
<scope>INTERACTION WITH GGA1 AND GGA2</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Biochem. J." volume="381" first="203" last="212">
<title>The mosaic receptor sorLA/LR11 binds components of the plasminogen-activating system and platelet-derived growth factor-BB similarly to LRP1 (low-density lipoprotein receptor-related protein), but mediates slow internalization of bound ligand.</title>
<authorList>
<person name="Gliemann J."/>
<person name="Hermey G."/>
<person name="Nykjaer A."/>
<person name="Petersen C.M."/>
<person name="Jacobsen C."/>
<person name="Andreasen P.A."/>
</authorList>
<dbReference type="PubMed" id="15053742"/>
<dbReference type="DOI" id="10.1042/bj20040149"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH LRPAP1; PDGFB; PLAT; PLAU AND SERPINE1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Circ. Res." volume="94" first="752" last="758">
<title>LR11, an LDL receptor gene family member, is a novel regulator of smooth muscle cell migration.</title>
<authorList>
<person name="Zhu Y."/>
<person name="Bujo H."/>
<person name="Yamazaki H."/>
<person name="Ohwaki K."/>
<person name="Jiang M."/>
<person name="Hirayama S."/>
<person name="Kanaki T."/>
<person name="Shibasaki M."/>
<person name="Takahashi K."/>
<person name="Schneider W.J."/>
<person name="Saito Y."/>
</authorList>
<dbReference type="PubMed" id="14764453"/>
<dbReference type="DOI" id="10.1161/01.res.0000120862.79154.0f"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PLAUR</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="50221" last="50229">
<title>Functional organization of the sortilin Vps10p domain.</title>
<authorList>
<person name="Westergaard U.B."/>
<person name="Soerensen E.S."/>
<person name="Hermey G."/>
<person name="Nielsen M.S."/>
<person name="Nykjaer A."/>
<person name="Kirkegaard K."/>
<person name="Jacobsen C."/>
<person name="Gliemann J."/>
<person name="Madsen P."/>
<person name="Petersen C.M."/>
</authorList>
<dbReference type="PubMed" id="15364913"/>
<dbReference type="DOI" id="10.1074/jbc.m408873200"/>
</citation>
<scope>INTERACTION WITH LRPAP1; GDNF AND PROPEPTIDE</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="13461" last="13466">
<title>Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.</title>
<authorList>
<person name="Andersen O.M."/>
<person name="Reiche J."/>
<person name="Schmidt V."/>
<person name="Gotthardt M."/>
<person name="Spoelgen R."/>
<person name="Behlke J."/>
<person name="von Arnim C.A."/>
<person name="Breiderhoff T."/>
<person name="Jansen P."/>
<person name="Wu X."/>
<person name="Bales K.R."/>
<person name="Cappai R."/>
<person name="Masters C.L."/>
<person name="Gliemann J."/>
<person name="Mufson E.J."/>
<person name="Hyman B.T."/>
<person name="Paul S.M."/>
<person name="Nykjaer A."/>
<person name="Willnow T.E."/>
</authorList>
<dbReference type="PubMed" id="16174740"/>
<dbReference type="DOI" id="10.1073/pnas.0503689102"/>
</citation>
<scope>FUNCTION IN APP TRAFFICKING</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH APP</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Biochem. J." volume="395" first="285" last="293">
<title>Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members.</title>
<authorList>
<person name="Hermey G."/>
<person name="Sjoegaard S.S."/>
<person name="Petersen C.M."/>
<person name="Nykjaer A."/>
<person name="Gliemann J."/>
</authorList>
<dbReference type="PubMed" id="16393139"/>
<dbReference type="DOI" id="10.1042/bj20051364"/>
</citation>
<scope>INTERACTION WITH PDGFB</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SHEDDING BY ADAM17</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="14547" last="14553">
<title>SorLA signaling by regulated intramembrane proteolysis.</title>
<authorList>
<person name="Boehm C."/>
<person name="Seibel N.M."/>
<person name="Henkel B."/>
<person name="Steiner H."/>
<person name="Haass C."/>
<person name="Hampe W."/>
</authorList>
<dbReference type="PubMed" id="16531402"/>
<dbReference type="DOI" id="10.1074/jbc.m601660200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CLEAVAGE BY PSEN1</scope>
<scope>MUTAGENESIS OF 2163-ARG-ARG-2164</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="J. Neurosci." volume="26" first="418" last="428">
<title>Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme.</title>
<authorList>
<person name="Spoelgen R."/>
<person name="von Arnim C.A."/>
<person name="Thomas A.V."/>
<person name="Peltan I.D."/>
<person name="Koker M."/>
<person name="Deng A."/>
<person name="Irizarry M.C."/>
<person name="Andersen O.M."/>
<person name="Willnow T.E."/>
<person name="Hyman B.T."/>
</authorList>
<dbReference type="PubMed" id="16407538"/>
<dbReference type="DOI" id="10.1523/jneurosci.3882-05.2006"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH APP AND BACE1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Biochemistry" volume="46" first="3896" last="3904">
<title>Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family.</title>
<authorList>
<person name="Nilsson S.K."/>
<person name="Lookene A."/>
<person name="Beckstead J.A."/>
<person name="Gliemann J."/>
<person name="Ryan R.O."/>
<person name="Olivecrona G."/>
</authorList>
<dbReference type="PubMed" id="17326667"/>
<dbReference type="DOI" id="10.1021/bi7000533"/>
</citation>
<scope>INTERACTION WITH APOA5</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="32956" last="32964">
<title>SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1.</title>
<authorList>
<person name="Schmidt V."/>
<person name="Sporbert A."/>
<person name="Rohe M."/>
<person name="Reimer T."/>
<person name="Rehm A."/>
<person name="Andersen O.M."/>
<person name="Willnow T.E."/>
</authorList>
<dbReference type="PubMed" id="17855360"/>
<dbReference type="DOI" id="10.1074/jbc.m705073200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH APP; GGA1 AND PACS1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 2190-ASP--ASP-2198 AND 2208-ASP--MET-2211</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="6842" last="6851">
<title>Sorting by the cytoplasmic domain of the amyloid precursor protein binding receptor SorLA.</title>
<authorList>
<person name="Nielsen M.S."/>
<person name="Gustafsen C."/>
<person name="Madsen P."/>
<person name="Nyengaard J.R."/>
<person name="Hermey G."/>
<person name="Bakke O."/>
<person name="Mari M."/>
<person name="Schu P."/>
<person name="Pohlmann R."/>
<person name="Dennes A."/>
<person name="Petersen C.M."/>
</authorList>
<dbReference type="PubMed" id="17646382"/>
<dbReference type="DOI" id="10.1128/mcb.00815-07"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PACS1; AP-1 COMPLEX AND AP-2 COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 2172-PHE--TYR-2177; 2190-ASP--ALA-2214; 2190-ASP--ASP-2198; 2201-MET-ILE-2202 AND 2211-MET--ALA-2214</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="25920" last="25927">
<title>Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families.</title>
<authorList>
<person name="Nilsson S.K."/>
<person name="Christensen S."/>
<person name="Raarup M.K."/>
<person name="Ryan R.O."/>
<person name="Nielsen M.S."/>
<person name="Olivecrona G."/>
</authorList>
<dbReference type="PubMed" id="18603531"/>
<dbReference type="DOI" id="10.1074/jbc.m802721200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH APOA5</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Neurosci. Lett." volume="440" first="190" last="192">
<title>No association of SORL1 SNPs with Alzheimer's disease.</title>
<authorList>
<person name="Minster R.L."/>
<person name="DeKosky S.T."/>
<person name="Kamboh M.I."/>
</authorList>
<dbReference type="PubMed" id="18562096"/>
<dbReference type="DOI" id="10.1016/j.neulet.2008.05.082"/>
</citation>
<scope>LACK OF ASSOCIATION WITH SUSCEPTIBILITY TO LATE-ONSET ALZHEIMER DISEASE</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-99; ASN-1733; ASN-2010; ASN-2076 AND ASN-2092</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="3027" last="3037">
<title>SORLA/SORL1 functionally interacts with SPAK to control renal activation of Na(+)-K(+)-Cl(-) cotransporter 2.</title>
<authorList>
<person name="Reiche J."/>
<person name="Theilig F."/>
<person name="Rafiqi F.H."/>
<person name="Carlo A.S."/>
<person name="Militz D."/>
<person name="Mutig K."/>
<person name="Todiras M."/>
<person name="Christensen E.I."/>
<person name="Ellison D.H."/>
<person name="Bader M."/>
<person name="Nykjaer A."/>
<person name="Bachmann S."/>
<person name="Alessi D."/>
<person name="Willnow T.E."/>
</authorList>
<dbReference type="PubMed" id="20385770"/>
<dbReference type="DOI" id="10.1128/mcb.01560-09"/>
</citation>
<scope>INTERACTION WITH STK39</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="Arch. Neurol." volume="68" first="99" last="106">
<title>Meta-analysis of the association between variants in SORL1 and Alzheimer disease.</title>
<authorList>
<consortium name="Genetic and Environmental Risk in Alzheimer Disease 1 Consortium"/>
<person name="Reitz C."/>
<person name="Cheng R."/>
<person name="Rogaeva E."/>
<person name="Lee J.H."/>
<person name="Tokuhiro S."/>
<person name="Zou F."/>
<person name="Bettens K."/>
<person name="Sleegers K."/>
<person name="Tan E.K."/>
<person name="Kimura R."/>
<person name="Shibata N."/>
<person name="Arai H."/>
<person name="Kamboh M.I."/>
<person name="Prince J.A."/>
<person name="Maier W."/>
<person name="Riemenschneider M."/>
<person name="Owen M."/>
<person name="Harold D."/>
<person name="Hollingworth P."/>
<person name="Cellini E."/>
<person name="Sorbi S."/>
<person name="Nacmias B."/>
<person name="Takeda M."/>
<person name="Pericak-Vance M.A."/>
<person name="Haines J.L."/>
<person name="Younkin S."/>
<person name="Williams J."/>
<person name="van Broeckhoven C."/>
<person name="Farrer L.A."/>
<person name="St George-Hyslop P.H."/>
<person name="Mayeux R."/>
</authorList>
<dbReference type="PubMed" id="21220680"/>
<dbReference type="DOI" id="10.1001/archneurol.2010.346"/>
</citation>
<scope>INVOLVEMENT IN AD</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="6117" last="6127">
<title>Rho kinase II phosphorylation of the lipoprotein receptor LR11/SORLA alters amyloid-beta production.</title>
<authorList>
<person name="Herskowitz J.H."/>
<person name="Seyfried N.T."/>
<person name="Gearing M."/>
<person name="Kahn R.A."/>
<person name="Peng J."/>
<person name="Levey A.I."/>
<person name="Lah J.J."/>
</authorList>
<dbReference type="PubMed" id="21147781"/>
<dbReference type="DOI" id="10.1074/jbc.m110.167239"/>
</citation>
<scope>PHOSPHORYLATION AT SER-2206</scope>
<scope>INTERACTION WITH ROCK2</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="41871" last="41882">
<title>Sorting protein-related receptor SorLA controls regulated secretion of glial cell line-derived neurotrophic factor.</title>
<authorList>
<person name="Geng Z."/>
<person name="Xu F.Y."/>
<person name="Huang S.H."/>
<person name="Chen Z.Y."/>
</authorList>
<dbReference type="PubMed" id="21994944"/>
<dbReference type="DOI" id="10.1074/jbc.m111.246413"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH GDNF</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="J. Cell Sci." volume="124" first="1095" last="1105">
<title>SorLA regulates the activity of lipoprotein lipase by intracellular trafficking.</title>
<authorList>
<person name="Klinger S.C."/>
<person name="Glerup S."/>
<person name="Raarup M.K."/>
<person name="Mari M.C."/>
<person name="Nyegaard M."/>
<person name="Koster G."/>
<person name="Prabakaran T."/>
<person name="Nilsson S.K."/>
<person name="Kjaergaard M.M."/>
<person name="Bakke O."/>
<person name="Nykjaer A."/>
<person name="Olivecrona G."/>
<person name="Petersen C.M."/>
<person name="Nielsen M.S."/>
</authorList>
<dbReference type="PubMed" id="21385844"/>
<dbReference type="DOI" id="10.1242/jcs.072538"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH LPL</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF 2211-MET--ALA-2214</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="Cell Rep." volume="3" first="186" last="199">
<title>SorLA controls neurotrophic activity by sorting of GDNF and its receptors GFRalpha1 and RET.</title>
<authorList>
<person name="Glerup S."/>
<person name="Lume M."/>
<person name="Olsen D."/>
<person name="Nyengaard J.R."/>
<person name="Vaegter C.B."/>
<person name="Gustafsen C."/>
<person name="Christensen E.I."/>
<person name="Kjolby M."/>
<person name="Hay-Schmidt A."/>
<person name="Bender D."/>
<person name="Madsen P."/>
<person name="Saarma M."/>
<person name="Nykjaer A."/>
<person name="Petersen C.M."/>
</authorList>
<dbReference type="PubMed" id="23333276"/>
<dbReference type="DOI" id="10.1016/j.celrep.2012.12.011"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH GDNF; GFRA1; GFRA2; GFRA3 AND GFRA4</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="11877" last="11886">
<title>The soluble form of LR11 protein is a regulator of hypoxia-induced, urokinase-type plasminogen activator receptor (uPAR)-mediated adhesion of immature hematological cells.</title>
<authorList>
<person name="Nishii K."/>
<person name="Nakaseko C."/>
<person name="Jiang M."/>
<person name="Shimizu N."/>
<person name="Takeuchi M."/>
<person name="Schneider W.J."/>
<person name="Bujo H."/>
</authorList>
<dbReference type="PubMed" id="23486467"/>
<dbReference type="DOI" id="10.1074/jbc.m112.442491"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PLAUR</scope>
<scope>INDUCTION BY HYPOXIA</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E58618" last="E58618">
<title>SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians.</title>
<authorList>
<consortium name="Alzheimer Disease Genetics Consortium"/>
<person name="Miyashita A."/>
<person name="Koike A."/>
<person name="Jun G."/>
<person name="Wang L.S."/>
<person name="Takahashi S."/>
<person name="Matsubara E."/>
<person name="Kawarabayashi T."/>
<person name="Shoji M."/>
<person name="Tomita N."/>
<person name="Arai H."/>
<person name="Asada T."/>
<person name="Harigaya Y."/>
<person name="Ikeda M."/>
<person name="Amari M."/>
<person name="Hanyu H."/>
<person name="Higuchi S."/>
<person name="Ikeuchi T."/>
<person name="Nishizawa M."/>
<person name="Suga M."/>
<person name="Kawase Y."/>
<person name="Akatsu H."/>
<person name="Kosaka K."/>
<person name="Yamamoto T."/>
<person name="Imagawa M."/>
<person name="Hamaguchi T."/>
<person name="Yamada M."/>
<person name="Moriaha T."/>
<person name="Takeda M."/>
<person name="Takao T."/>
<person name="Nakata K."/>
<person name="Fujisawa Y."/>
<person name="Sasaki K."/>
<person name="Watanabe K."/>
<person name="Nakashima K."/>
<person name="Urakami K."/>
<person name="Ooya T."/>
<person name="Takahashi M."/>
<person name="Yuzuriha T."/>
<person name="Serikawa K."/>
<person name="Yoshimoto S."/>
<person name="Nakagawa R."/>
<person name="Kim J.W."/>
<person name="Ki C.S."/>
<person name="Won H.H."/>
<person name="Na D.L."/>
<person name="Seo S.W."/>
<person name="Mook-Jung I."/>
<person name="St George-Hyslop P."/>
<person name="Mayeux R."/>
<person name="Haines J.L."/>
<person name="Pericak-Vance M.A."/>
<person name="Yoshida M."/>
<person name="Nishida N."/>
<person name="Tokunaga K."/>
<person name="Yamamoto K."/>
<person name="Tsuji S."/>
<person name="Kanazawa I."/>
<person name="Ihara Y."/>
<person name="Schellenberg G.D."/>
<person name="Farrer L.A."/>
<person name="Kuwano R."/>
</authorList>
<dbReference type="PubMed" id="23565137"/>
<dbReference type="DOI" id="10.1371/journal.pone.0058618"/>
</citation>
<scope>INVOLVEMENT IN AD</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E72164" last="E72164">
<title>SORLA-mediated trafficking of TrkB enhances the response of neurons to BDNF.</title>
<authorList>
<person name="Rohe M."/>
<person name="Hartl D."/>
<person name="Fjorback A.N."/>
<person name="Klose J."/>
<person name="Willnow T.E."/>
</authorList>
<dbReference type="PubMed" id="23977241"/>
<dbReference type="DOI" id="10.1371/journal.pone.0072164"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2014" name="Sci. Transl. Med." volume="6" first="223RA20" last="223RA20">
<title>Lysosomal sorting of amyloid-beta by the SORLA receptor is impaired by a familial Alzheimer's disease mutation.</title>
<authorList>
<person name="Caglayan S."/>
<person name="Takagi-Niidome S."/>
<person name="Liao F."/>
<person name="Carlo A.S."/>
<person name="Schmidt V."/>
<person name="Burgert T."/>
<person name="Kitago Y."/>
<person name="Fuechtbauer E.M."/>
<person name="Fuechtbauer A."/>
<person name="Holtzman D.M."/>
<person name="Takagi J."/>
<person name="Willnow T.E."/>
</authorList>
<dbReference type="PubMed" id="24523320"/>
<dbReference type="DOI" id="10.1126/scitranslmed.3007747"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH APP AND PROPEPTIDE</scope>
<scope>CHARACTERIZATION OF VARIANT AD ARG-511</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2015" name="Nat. Commun." volume="6" first="8951" last="8951">
<title>Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans.</title>
<authorList>
<person name="Whittle A.J."/>
<person name="Jiang M."/>
<person name="Peirce V."/>
<person name="Relat J."/>
<person name="Virtue S."/>
<person name="Ebinuma H."/>
<person name="Fukamachi I."/>
<person name="Yamaguchi T."/>
<person name="Takahashi M."/>
<person name="Murano T."/>
<person name="Tatsuno I."/>
<person name="Takeuchi M."/>
<person name="Nakaseko C."/>
<person name="Jin W."/>
<person name="Jin Z."/>
<person name="Campbell M."/>
<person name="Schneider W.J."/>
<person name="Vidal-Puig A."/>
<person name="Bujo H."/>
</authorList>
<dbReference type="PubMed" id="26584636"/>
<dbReference type="DOI" id="10.1038/ncomms9951"/>
</citation>
<scope>POTENTIAL ASSOCIATION WITH BODY MASS INDEX</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2016" name="J. Clin. Invest." volume="126" first="2706" last="2720">
<title>SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity.</title>
<authorList>
<person name="Schmidt V."/>
<person name="Schulz N."/>
<person name="Yan X."/>
<person name="Schuermann A."/>
<person name="Kempa S."/>
<person name="Kern M."/>
<person name="Blueher M."/>
<person name="Poy M.N."/>
<person name="Olivecrona G."/>
<person name="Willnow T.E."/>
</authorList>
<dbReference type="PubMed" id="27322061"/>
<dbReference type="DOI" id="10.1172/jci84708"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH INSR</scope>
<scope>POTENTIAL ASSOCIATION WITH BODY MASS INDEX</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2016" name="Mol. Cell. Biol." volume="36" first="1272" last="1286">
<title>Cytokine-like factor 1, an essential facilitator of cardiotrophin-like cytokine:ciliary neurotrophic factor receptor alpha signaling and sorLA-mediated turnover.</title>
<authorList>
<person name="Larsen J.V."/>
<person name="Kristensen A.M."/>
<person name="Pallesen L.T."/>
<person name="Bauer J."/>
<person name="Vaegter C.B."/>
<person name="Nielsen M.S."/>
<person name="Madsen P."/>
<person name="Petersen C.M."/>
</authorList>
<dbReference type="PubMed" id="26858303"/>
<dbReference type="DOI" id="10.1128/mcb.00917-15"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CLCF1; CRLF1; CNTFR AND LRPAP1</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2017" name="Mol. Cell. Biol." volume="37">
<title>SorLA in Interleukin-6 Signaling and Turnover.</title>
<authorList>
<person name="Larsen J.V."/>
<person name="Petersen C.M."/>
</authorList>
<dbReference type="PubMed" id="28265003"/>
<dbReference type="DOI" id="10.1128/mcb.00641-16"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IL6 AND IL6R</scope>
<scope>SHEDDING FROM THE CELL SURFACE</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2019" name="Clin. Chim. Acta" volume="489" first="29" last="34">
<title>Soluble LR11 competes with amyloid beta in binding to cerebrospinal fluid-high-density lipoprotein.</title>
<authorList>
<person name="Yano K."/>
<person name="Hirayama S."/>
<person name="Misawa N."/>
<person name="Furuta A."/>
<person name="Ueno T."/>
<person name="Motoi Y."/>
<person name="Seino U."/>
<person name="Ebinuma H."/>
<person name="Ikeuchi T."/>
<person name="Schneider W.J."/>
<person name="Bujo H."/>
<person name="Miida T."/>
</authorList>
<dbReference type="PubMed" id="30448281"/>
<dbReference type="DOI" id="10.1016/j.cca.2018.11.024"/>
</citation>
<scope>INTERACTION WITH APOE</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2019" name="Nat. Commun." volume="10" first="2340" last="2340">
<title>SORLA regulates endosomal trafficking and oncogenic fitness of HER2.</title>
<authorList>
<person name="Pietilae M."/>
<person name="Sahgal P."/>
<person name="Peuhu E."/>
<person name="Jaentti N.Z."/>
<person name="Paatero I."/>
<person name="Naervae E."/>
<person name="Al-Akhrass H."/>
<person name="Lilja J."/>
<person name="Georgiadou M."/>
<person name="Andersen O.M."/>
<person name="Padzik A."/>
<person name="Sihto H."/>
<person name="Joensuu H."/>
<person name="Blomqvist M."/>
<person name="Saarinen I."/>
<person name="Bostroem P.J."/>
<person name="Taimen P."/>
<person name="Ivaska J."/>
</authorList>
<dbReference type="PubMed" id="31138794"/>
<dbReference type="DOI" id="10.1038/s41467-019-10275-0"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ERBB2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2019" name="Sci. Rep." volume="9" first="611" last="611">
<title>HSPA12A targets the cytoplasmic domain and affects the trafficking of the Amyloid Precursor Protein receptor SorLA.</title>
<authorList>
<person name="Madsen P."/>
<person name="Isaksen T.J."/>
<person name="Siupka P."/>
<person name="Toth A.E."/>
<person name="Nyegaard M."/>
<person name="Gustafsen C."/>
<person name="Nielsen M.S."/>
</authorList>
<dbReference type="PubMed" id="30679749"/>
<dbReference type="DOI" id="10.1038/s41598-018-37336-6"/>
</citation>
<scope>INTERACTION WITH GGA1 AND HSPA12A</scope>
<scope>MUTAGENESIS OF 2190-ASP-ASP-2191; 2194-GLU--ASP-2198; 2203-THR-GLY-2204; 2205-PHE-SER-2206; 2207-ASP-ASP-2208 AND 2209-VAL-PRO-2210</scope>
</reference>
<reference key="42">
<citation type="submission" date="2006-10" db="PDB data bank">
<title>Solution structure of the second FN3 domain of human SORLA/LR11.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 1651-1745</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2010" name="Traffic" volume="11" first="259" last="273">
<title>GGA autoinhibition revisited.</title>
<authorList>
<person name="Cramer J.F."/>
<person name="Gustafsen C."/>
<person name="Behrens M.A."/>
<person name="Oliveira C.L."/>
<person name="Pedersen J.S."/>
<person name="Madsen P."/>
<person name="Petersen C.M."/>
<person name="Thirup S.S."/>
</authorList>
<dbReference type="PubMed" id="20015111"/>
<dbReference type="DOI" id="10.1111/j.1600-0854.2009.01017.x"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 2202-2214 IN COMPLEX WITH GGA1</scope>
<scope>INTERACTION WITH GGA1</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] SER-120; LEU-1581 AND VAL-1972</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="Hum. Mutat." volume="29" first="769" last="770">
<title>SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population.</title>
<authorList>
<person name="Bettens K."/>
<person name="Brouwers N."/>
<person name="Engelborghs S."/>
<person name="De Deyn P.P."/>
<person name="Van Broeckhoven C."/>
<person name="Sleegers K."/>
</authorList>
<dbReference type="PubMed" id="18407551"/>
<dbReference type="DOI" id="10.1002/humu.20725"/>
</citation>
<scope>POSSIBLE ASSOCIATION WITH SUSCEPTIBILITY TO LATE-ONSET ALZHEIMER DISEASE</scope>
<scope>VARIANT THR-528</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2012" name="Mol. Psychiatry" volume="17" first="875" last="879">
<title>High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease.</title>
<authorList>
<consortium name="PHRC GMAJ Collaborators"/>
<person name="Pottier C."/>
<person name="Hannequin D."/>
<person name="Coutant S."/>
<person name="Rovelet-Lecrux A."/>
<person name="Wallon D."/>
<person name="Rousseau S."/>
<person name="Legallic S."/>
<person name="Paquet C."/>
<person name="Bombois S."/>
<person name="Pariente J."/>
<person name="Thomas-Anterion C."/>
<person name="Michon A."/>
<person name="Croisile B."/>
<person name="Etcharry-Bouyx F."/>
<person name="Berr C."/>
<person name="Dartigues J.F."/>
<person name="Amouyel P."/>
<person name="Dauchel H."/>
<person name="Boutoleau-Bretonniere C."/>
<person name="Thauvin C."/>
<person name="Frebourg T."/>
<person name="Lambert J.C."/>
<person name="Campion D."/>
</authorList>
<dbReference type="PubMed" id="22472873"/>
<dbReference type="DOI" id="10.1038/mp.2012.15"/>
</citation>
<scope>VARIANTS AD CYS-141; ARG-511; SER-924; SER-1358 AND ASP-1681</scope>
</reference>
<comment type="function">
<text evidence="6 15 19 21 25 26 28 34 35 37 38 40 41 42 43 44 47 54">Sorting receptor that directs several proteins to their correct location within the cell (Probable). Along with AP-1 complex, involved Golgi apparatus - endosome sorting (PubMed:17646382). Sorting receptor for APP, regulating its intracellular trafficking and processing into amyloidogenic-beta peptides. Retains APP in the trans-Golgi network, hence preventing its transit through late endosomes where amyloid beta peptides Abeta40 and Abeta42 are generated (PubMed:16174740, PubMed:16407538, PubMed:17855360, PubMed:24523320). May also sort newly produced amyloid-beta peptides to lysosomes for catabolism (PubMed:24523320). Does not affect APP trafficking from the endoplasmic reticulum to Golgi compartments (PubMed:17855360). Sorting receptor for the BDNF receptor NTRK2/TRKB that facilitates NTRK2 trafficking between synaptic plasma membranes, postsynaptic densities and cell soma, hence positively regulates BDNF signaling by controlling the intracellular location of its receptor (PubMed:23977241). Sorting receptor for GDNF that promotes GDNF regulated, but not constitutive secretion (PubMed:21994944). Sorting receptor for the GDNF-GFRA1 complex, directing it from the cell surface to endosomes. GDNF is then targeted to lysosomes and degraded, while its receptor GFRA1 recycles back to the cell membrane, resulting in a GDNF clearance pathway. The SORL1-GFRA1 complex further targets RET for endocytosis, but not for degradation, affecting GDNF-induced neurotrophic activities (PubMed:23333276). Sorting receptor for ERBB2/HER2. Regulates ERBB2 subcellular distribution by promoting its recycling after internalization from endosomes back to the plasma membrane, hence stimulating phosphoinositide 3-kinase (PI3K)-dependent ERBB2 signaling. In ERBB2-dependent cancer cells, promotes cell proliferation (PubMed:31138794). Sorting receptor for lipoprotein lipase LPL. Promotes LPL localization to endosomes and later to the lysosomes, leading to degradation of newly synthesized LPL (PubMed:21385844). Potential sorting receptor for APOA5, inducing APOA5 internalization to early endosomes, then to late endosomes, wherefrom a portion is sent to lysosomes and degradation, another portion is sorted to the trans-Golgi network (PubMed:18603531). Sorting receptor for the insulin receptor INSR. Promotes recycling of internalized INSR via the Golgi apparatus back to the cell surface, thereby preventing lysosomal INSR catabolism, increasing INSR cell surface expression and strengthening insulin signal reception in adipose tissue. Does not affect INSR internalization (PubMed:27322061). Plays a role in renal ion homeostasis, controlling the phospho-regulation of SLC12A1/NKCC2 by STK39/SPAK kinase and PPP3CB/calcineurin A beta phosphatase, possibly through intracellular sorting of STK39 and PPP3CB (By similarity). Stimulates, via the N-terminal ectodomain, the proliferation and migration of smooth muscle cells, possibly by increasing cell surface expression of the urokinase receptor uPAR/PLAUR. This may promote extracellular matrix proteolysis and hence facilitate cell migration (PubMed:14764453). By acting on the migration of intimal smooth muscle cells, may accelerate intimal thickening following vascular injury (PubMed:14764453). Promotes adhesion of monocytes (PubMed:23486467). Stimulates proliferation and migration of monocytes/macrophages (By similarity). Through its action on intimal smooth muscle cells and macrophages, may accelerate intimal thickening and macrophage foam cell formation in the process of atherosclerosis (By similarity). Regulates hypoxia-enhanced adhesion of hematopoietic stem and progenitor cells to the bone marrow stromal cells via a PLAUR-mediated pathway. This function is mediated by the N-terminal ectodomain (PubMed:23486467). Metabolic regulator, which functions to maintain the adequate balance between lipid storage and oxidation in response to changing environmental conditions, such as temperature and diet. The N-terminal ectodomain negatively regulates adipose tissue energy expenditure, acting through the inhibition the BMP/Smad pathway (By similarity). May regulate signaling by the heterodimeric neurotrophic cytokine CLCF1-CRLF1 bound to the CNTFR receptor by promoting the endocytosis of the tripartite complex CLCF1-CRLF1-CNTFR and lysosomal degradation (PubMed:26858303). May regulate IL6 signaling, decreasing cis signaling, possibly by interfering with IL6-binding to membrane-bound IL6R, while up-regulating trans signaling via soluble IL6R (PubMed:28265003).</text>
</comment>
<comment type="subunit">
<text evidence="6 7 11 12 13 14 15 16 17 19 20 21 24 25 26 28 30 31 32 34 35 37 38 41 42 43 44 45 46 47 48">After maturation cleavage, interacts (via N-terminus) with its own propeptide; this interaction prevents interaction with other ligands, including CRLF1, GDNF, GFRA1, IL6 and IL6R (PubMed:11294867, PubMed:12530537, PubMed:15364913, PubMed:23333276, PubMed:24523320). Interacts (via N-terminal ectodomain) with APP, forming a 1:1 stoichiometric complex, including with isoforms APP695, APP751 and APP770; this interaction retains APP in the trans-Golgi network and reduces processing into soluble APP-alpha and amyloid-beta peptides (PubMed:16174740, PubMed:16407538, PubMed:17855360, PubMed:24523320). Also interacts with APP C-terminal fragment C99 and with Abeta40 (PubMed:16407538). Interacts with beta-secretase BACE1/BACE; this interaction may affect BACE1-binding to APP and hence reduce BACE1-dependent APP cleavage (PubMed:16407538). Interacts with LRPAP1/RAP (PubMed:8940146, PubMed:11294867, PubMed:12530537, PubMed:15053742, PubMed:14764453, PubMed:15364913, PubMed:26858303). Interacts (via C-terminal cytosolic domain) with GGA1 and GGA2 (via N-terminal VHS domain) (PubMed:11821067, PubMed:17855360, PubMed:30679749, PubMed:20015111). Interacts with PACS1 (PubMed:17855360, PubMed:17646382). May interact (via the N-terminal ectodomain) with the morphogenetic neuropeptide, also called head activator or HA; this interaction is impaired in the presence of propeptide (PubMed:11082041, PubMed:11294867, PubMed:12530537). Interacts with neurotensin/NTS (PubMed:11294867). Interacts (via the N-terminal ectodomain) with PDGFB homodimer (PubMed:15053742, PubMed:16393139). Interacts (via N-terminal ectodomain) with the uPA receptor PLAUR; this interaction decreases PLAUR internalization (PubMed:14764453, PubMed:23486467). Interacts (via N-terminal ectodomain) with uPA/PLAU and PAI1/SERPINE1, either individually or in complex with each other, leading to endocytosis; this interaction is abolished in the presence of LRPAP1 (PubMed:15053742). Also interacts with the ternary complex composed of PLAUR-PLAU-PAI1 (PubMed:15053742). Also interacts with tPA/PLAT either alone or in complex with SERPINE1 (PubMed:15053742). Interacts (via C-terminus) with AP-1 and AP-2 complexes (PubMed:17646382). Interacts with BMPR1A and BMPR1B (By similarity). Interacts with lipoprotein lipase LPL; this interaction is optimal in slightly acidic conditions (PubMed:21385844). Interacts (via N-terminal ectodomain) with GDNF (via propeptide) and GDNF receptor alpha-1/GFRA1, either individually or in complex with each other (PubMed:15364913, PubMed:21994944, PubMed:23333276). The interaction with GDNF occurs mostly intracellularly (PubMed:21994944). Also interacts with other GDNF receptor alpha family members, including GFRA2, GFRA3 and GFRA4 (PubMed:23333276). Interacts with the insulin receptor INSR; this interaction strongly increases the surface exposure of INSR (PubMed:27322061). Interacts (via cytosolic C-terminus) with STK39/SPAK (PubMed:20385770). Interacts (via N-terminal ectodomain) with the heterodimeric complex CRLF1-CLC; within this complex, the interaction is mediated predominantly by the CRLF1 moiety (PubMed:26858303). Interacts with CNTFR, as well as with the tripartite signaling complex formed by CRLF1, CLC and CNTFR (PubMed:26858303). Interacts (via N-terminal ectodomain) with IL6; this interaction leads to IL6 internalization and lysosomal degradation (PubMed:28265003). Binding of SOLRL1 secreted N-terminal ectodomain to IL6 may increase IL6 trans signaling (PubMed:28265003). Interacts with secreted IL6R; this interaction leads to IL6R internalization (PubMed:28265003). Also interacts with transmembrane IL6R; this interaction does not affect IL6R subcellular location (PubMed:28265003). Interacts with APOE (PubMed:30448281). Interacts with apolipoprotein E-rich beta-VLDL (By similarity). Interacts with APOA5; this interaction leads to APOA5 internalization and is abolished by heparin (PubMed:17326667, PubMed:18603531). Interaction with APOA5 results in enhanced binding to chylomicrons (PubMed:17326667). Interacts with ROCK2 (PubMed:21147781). Interacts (via cytosolic C-terminus) with PPP3CB/calcineurin A beta (By similarity). Interacts with NTRK2/TRKB; this interaction facilitates NTRK2 trafficking between synaptic plasma membranes, postsynaptic densities and cell soma, hence positively regulates BDNF signaling (By similarity). Interacts (via cytosolic C-terminus) with HSPA12A in an ADP-dependent manner; this interaction affects SORL1 internalization and subcellular localization (PubMed:30679749). Interacts (via N-terminal ectodomain) with ERBB2/HER2 (PubMed:31138794).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-302641">
<id>P05067-4</id>
<label>APP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-3894543">
<id>PRO_0000000091</id>
<label>APP</label>
<dbReference type="UniProtKB" id="P05067"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-2431589">
<id>PRO_0000000093</id>
<label>APP</label>
<dbReference type="UniProtKB" id="P05067"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-743758">
<id>P26992</id>
<label>CNTFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-15587902">
<id>O75462</id>
<label>CRLF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-742054">
<id>Q96D03</id>
<label>DDIT4L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-25397146">
<id>PRO_0000034005</id>
<label>GDNF</label>
<dbReference type="UniProtKB" id="P39905"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-15854635">
<id>P56159-2</id>
<label>GFRA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-447141">
<id>Q9UJY5</id>
<label>GGA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-296980">
<id>O43301</id>
<label>HSPA12A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-720533">
<id>P05231</id>
<label>IL6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-299383">
<id>P08887</id>
<label>IL6R</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-715927">
<id>P30533</id>
<label>LRPAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-12029004">
<id>P78424</id>
<label>POU6F2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-1244971">
<id>Q15669</id>
<label>RHOH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-25298876">
<id>PRO_0000033164</id>
<label>SORL1</label>
<dbReference type="UniProtKB" id="Q92673"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1171329">
<id>Q92673</id>
</interactant>
<interactant intactId="EBI-25397991">
<id>Q62997</id>
<label>Gfra1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="12 19 26 34 35">Golgi apparatus membrane</location>
<topology evidence="54">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="25 34 37">Golgi apparatus</location>
<location evidence="25 34 37">trans-Golgi network membrane</location>
<topology evidence="54">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="34 37">Endosome membrane</location>
<topology evidence="54">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="19 25 34 47">Early endosome membrane</location>
<topology evidence="54">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="26 47">Recycling endosome membrane</location>
<topology evidence="54">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="26 34">Endoplasmic reticulum membrane</location>
<topology evidence="54">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="34 37">Endosome</location>
<location evidence="34 37">Multivesicular body membrane</location>
<topology evidence="54">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="12 15 16 26 34 35 47">Cell membrane</location>
<topology evidence="54">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="35">Cytoplasmic vesicle</location>
<location evidence="35">Secretory vesicle membrane</location>
<topology evidence="54">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="11 15 16 20 22">Secreted</location>
</subcellularLocation>
<text evidence="11 12 16 20 22 25 26 34 35 47">Mostly intracellular, predominantly in the trans-Golgi network (TGN) and in endosome, as well as in endosome-to-TGN retrograde vesicles; found at low levels on the plasma membrane (PubMed:11294867, PubMed:15053742, PubMed:17855360, PubMed:21994944, PubMed:21385844, PubMed:31138794). At the cell surface, partially subjected to proteolytic shedding that releases the ectodomain (also called soluble SORLA, solLR11 or sLR11) in the extracellular milieu (PubMed:11082041, PubMed:16393139, PubMed:16531402). The shedding may be catalyzed by ADAM17/TACE (PubMed:16393139). Following shedding, PSEN1/presenilin-1 cleaves the remaining transmembrane fragment and catalyzes the release of a C-terminal fragment in the cytosol and of a soluble N-terminal beta fragment in the extracellular milieu. The C-terminal cytosolic fragment localizes to the nucleus (PubMed:16531402). At the cell surface, the full-length protein undergoes partial clathrin-dependent endocytosis guided by clathrin adapter protein 2 (AP-2) (PubMed:11294867, PubMed:15053742, PubMed:17646382).</text>
</comment>
<comment type="tissue specificity">
<text evidence="19 32 48 49">Highly expressed in brain (at protein level) (PubMed:9157966, PubMed:16174740, PubMed:21147781). Most abundant in the cerebellum, cerebral cortex and occipital pole; low levels in the putamen and thalamus (PubMed:9157966, PubMed:16174740). Expression is significantly reduced in the frontal cortex of patients suffering from Alzheimer disease (PubMed:16174740). Also expressed in spinal cord, spleen, testis, prostate, ovary, tyroid and lymph nodes (PubMed:9157966, PubMed:8940146).</text>
</comment>
<comment type="induction">
<text evidence="11 38">Up-regulated by morphogenetic neuropeptide, also called head activator or HA (PubMed:11082041). Up-regulated under hypoxic conditions in hematopoietic stem and progenitor cells, a physiological condition encountered by these cells in the endosteum. This up-regulation may be mediated by HIF1A-induced transcription (PubMed:23486467).</text>
</comment>
<comment type="PTM">
<text evidence="11 12 20 22 44 55 56">Within the Golgi apparatus, the propeptide may be cleaved off by FURIN or a furin-like protease (Probable). After cleavage, the propeptide interacts with the mature protein N-terminus, preventing the association with other ligands (PubMed:11294867). At the cell surface, partially subjected to proteolytic shedding that releases the ectodomain in the extracellular milieu (PubMed:11082041, PubMed:16393139, PubMed:16531402, PubMed:28265003). The shedding may be catalyzed by ADAM17/TACE (PubMed:16393139, PubMed:16531402). Following shedding, PSEN1/presenilin-1 cleaves the remaining transmembrane fragment and catalyzes the release of a C-terminal fragment in the cytosol and of a soluble N-terminal beta fragment in the extracellular milieu. The C-terminal cytosolic fragment localizes to the nucleus (PubMed:16531402).</text>
</comment>
<comment type="PTM">
<text evidence="30">Phosphorylation at Ser-2206 facilitates the interaction with GGA1.</text>
</comment>
<comment type="disease" evidence="33 36 39 41">
<disease id="DI-03832">
<name>Alzheimer disease</name>
<acronym>AD</acronym>
<description>Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituents of these plaques are neurotoxic amyloid-beta protein 40 and amyloid-beta protein 42, that are produced by the proteolysis of the transmembrane APP protein. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products, such as C31, are also implicated in neuronal death.</description>
<dbReference type="MIM" id="104300"/>
</disease>
<text>The gene represented in this entry may be involved in disease pathogenesis.</text>
</comment>
<comment type="miscellaneous">
<text evidence="43">There may be a positive correlation of body mass index with levels of SORL1 transcript and SORLA protein in visceral adipose tissue.</text>
</comment>
<comment type="similarity">
<text evidence="54">Belongs to the VPS10-related sortilin family. SORL1 subfamily.</text>
</comment>
<dbReference type="EMBL" id="Y08110">
<property type="protein sequence ID" value="CAA69325.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U60975">
<property type="protein sequence ID" value="AAC50891.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000664">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000977">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471065">
<property type="protein sequence ID" value="EAW67525.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC137171">
<property type="protein sequence ID" value="AAI37172.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8436.1"/>
<dbReference type="RefSeq" id="NP_003096.1">
<property type="nucleotide sequence ID" value="NM_003105.5"/>
</dbReference>
<dbReference type="PDB" id="2DM4">
<property type="method" value="NMR"/>
<property type="chains" value="A=1651-1745"/>
</dbReference>
<dbReference type="PDB" id="3G2S">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="C/D=2202-2214"/>
</dbReference>
<dbReference type="PDB" id="3G2T">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C/D=2202-2214"/>
</dbReference>
<dbReference type="PDB" id="3WSX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=29-753"/>
</dbReference>
<dbReference type="PDB" id="3WSY">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.11"/>
<property type="chains" value="A=86-753, C=42-56"/>
</dbReference>
<dbReference type="PDB" id="3WSZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=86-753"/>
</dbReference>
<dbReference type="PDBsum" id="2DM4"/>
<dbReference type="PDBsum" id="3G2S"/>
<dbReference type="PDBsum" id="3G2T"/>
<dbReference type="PDBsum" id="3WSX"/>
<dbReference type="PDBsum" id="3WSY"/>
<dbReference type="PDBsum" id="3WSZ"/>
<dbReference type="BMRB" id="Q92673"/>
<dbReference type="SMR" id="Q92673"/>
<dbReference type="BioGRID" id="112536">
<property type="interactions" value="73"/>
</dbReference>
<dbReference type="DIP" id="DIP-41229N"/>
<dbReference type="IntAct" id="Q92673">
<property type="interactions" value="63"/>
</dbReference>
<dbReference type="MINT" id="Q92673"/>
<dbReference type="STRING" id="9606.ENSP00000260197"/>
<dbReference type="TCDB" id="9.B.87.1.17">
<property type="family name" value="the selenoprotein p receptor (selp-receptor) family"/>
</dbReference>
<dbReference type="GlyConnect" id="1766">
<property type="glycosylation" value="17 N-Linked glycans (11 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="Q92673">
<property type="glycosylation" value="43 sites, 3 O-linked glycans (8 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q92673"/>
<dbReference type="PhosphoSitePlus" id="Q92673"/>
<dbReference type="BioMuta" id="SORL1"/>
<dbReference type="DMDM" id="296452912"/>
<dbReference type="EPD" id="Q92673"/>
<dbReference type="jPOST" id="Q92673"/>
<dbReference type="MassIVE" id="Q92673"/>
<dbReference type="MaxQB" id="Q92673"/>
<dbReference type="PaxDb" id="Q92673"/>
<dbReference type="PeptideAtlas" id="Q92673"/>
<dbReference type="PRIDE" id="Q92673"/>
<dbReference type="ProteomicsDB" id="75402"/>
<dbReference type="ABCD" id="Q92673">
<property type="antibodies" value="1 sequenced antibody"/>
</dbReference>
<dbReference type="Antibodypedia" id="32786">
<property type="antibodies" value="238 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000260197">
<property type="protein sequence ID" value="ENSP00000260197"/>
<property type="gene ID" value="ENSG00000137642"/>
</dbReference>
<dbReference type="GeneID" id="6653"/>
<dbReference type="KEGG" id="hsa:6653"/>
<dbReference type="UCSC" id="uc001pxx.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6653"/>
<dbReference type="DisGeNET" id="6653"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000137642.12"/>
<dbReference type="GeneCards" id="SORL1"/>
<dbReference type="HGNC" id="HGNC:11185">
<property type="gene designation" value="SORL1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000137642">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="SORL1"/>
<dbReference type="MIM" id="104300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="602005">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q92673"/>
<dbReference type="NIAGADS" id="ENSG00000137642"/>
<dbReference type="OpenTargets" id="ENSG00000137642"/>
<dbReference type="Orphanet" id="1020">
<property type="disease" value="Early-onset autosomal dominant Alzheimer disease"/>
</dbReference>
<dbReference type="Orphanet" id="238616">
<property type="disease" value="NON RARE IN EUROPE: Alzheimer disease"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36022"/>
<dbReference type="eggNOG" id="KOG1215">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="KOG3511">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00990000203671"/>
<dbReference type="HOGENOM" id="CLU_001389_0_0_1"/>
<dbReference type="InParanoid" id="Q92673"/>
<dbReference type="OMA" id="IEGMAFD"/>
<dbReference type="OrthoDB" id="1046610at2759"/>
<dbReference type="PhylomeDB" id="Q92673"/>
<dbReference type="TreeFam" id="TF324918"/>
<dbReference type="PathwayCommons" id="Q92673"/>
<dbReference type="Reactome" id="R-HSA-977225">
<property type="pathway name" value="Amyloid fiber formation"/>
</dbReference>
<dbReference type="SIGNOR" id="Q92673"/>
<dbReference type="BioGRID-ORCS" id="6653">
<property type="hits" value="9 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SORL1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q92673"/>
<dbReference type="GenomeRNAi" id="6653"/>
<dbReference type="Pharos" id="Q92673">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q92673"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="RNAct" id="Q92673">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000137642">
<property type="expression patterns" value="Expressed in blood and 246 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q92673">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q92673">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031901">
<property type="term" value="C:early endosome membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031985">
<property type="term" value="C:Golgi cisterna"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005771">
<property type="term" value="C:multivesicular body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032585">
<property type="term" value="C:multivesicular body membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005641">
<property type="term" value="C:nuclear envelope lumen"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0097356">
<property type="term" value="C:perinucleolar compartment"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055037">
<property type="term" value="C:recycling endosome"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0055038">
<property type="term" value="C:recycling endosome membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005802">
<property type="term" value="C:trans-Golgi network"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0030658">
<property type="term" value="C:transport vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0030306">
<property type="term" value="F:ADP-ribosylation factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0001540">
<property type="term" value="F:amyloid-beta binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0030169">
<property type="term" value="F:low-density lipoprotein particle binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005041">
<property type="term" value="F:low-density lipoprotein particle receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042923">
<property type="term" value="F:neuropeptide binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990845">
<property type="term" value="P:adaptive thermogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002024">
<property type="term" value="P:diet induced thermogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038020">
<property type="term" value="P:insulin receptor recycling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902430">
<property type="term" value="P:negative regulation of amyloid-beta formation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1902960">
<property type="term" value="P:negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0030514">
<property type="term" value="P:negative regulation of BMP signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043407">
<property type="term" value="P:negative regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1902963">
<property type="term" value="P:negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1902997">
<property type="term" value="P:negative regulation of neurofibrillary tangle assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0050768">
<property type="term" value="P:negative regulation of neurogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1901215">
<property type="term" value="P:negative regulation of neuron death"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0032091">
<property type="term" value="P:negative regulation of protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0031333">
<property type="term" value="P:negative regulation of protein-containing complex assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1902948">
<property type="term" value="P:negative regulation of tau-protein kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0010897">
<property type="term" value="P:negative regulation of triglyceride catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007218">
<property type="term" value="P:neuropeptide signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904179">
<property type="term" value="P:positive regulation of adipose tissue development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902771">
<property type="term" value="P:positive regulation of choline O-acetyltransferase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1902955">
<property type="term" value="P:positive regulation of early endosome to recycling endosome transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:2001137">
<property type="term" value="P:positive regulation of endocytic recycling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1902953">
<property type="term" value="P:positive regulation of ER to Golgi vesicle-mediated transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1900168">
<property type="term" value="P:positive regulation of glial cell-derived neurotrophic factor secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046628">
<property type="term" value="P:positive regulation of insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045732">
<property type="term" value="P:positive regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0070863">
<property type="term" value="P:positive regulation of protein exit from endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:1902966">
<property type="term" value="P:positive regulation of protein localization to early endosome"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0006892">
<property type="term" value="P:post-Golgi vesicle-mediated transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0034067">
<property type="term" value="P:protein localization to Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0051604">
<property type="term" value="P:protein maturation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0045053">
<property type="term" value="P:protein retention in Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0006605">
<property type="term" value="P:protein targeting"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006622">
<property type="term" value="P:protein targeting to lysosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0006898">
<property type="term" value="P:receptor-mediated endocytosis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014910">
<property type="term" value="P:regulation of smooth muscle cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00063">
<property type="entry name" value="FN3"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="CDD" id="cd00112">
<property type="entry name" value="LDLa"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="Gene3D" id="2.120.10.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.130.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.400.10">
<property type="match status" value="11"/>
</dbReference>
<dbReference type="InterPro" id="IPR011042">
<property type="entry name" value="6-blade_b-propeller_TolB-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR003961">
<property type="entry name" value="FN3_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036116">
<property type="entry name" value="FN3_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR036055">
<property type="entry name" value="LDL_receptor-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR023415">
<property type="entry name" value="LDLR_class-A_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000033">
<property type="entry name" value="LDLR_classB_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR002172">
<property type="entry name" value="LDrepeatLR_classA_rpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR031777">
<property type="entry name" value="Sortilin_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR031778">
<property type="entry name" value="Sortilin_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR006581">
<property type="entry name" value="VPS10"/>
</dbReference>
<dbReference type="InterPro" id="IPR015943">
<property type="entry name" value="WD40/YVTN_repeat-like_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00041">
<property type="entry name" value="fn3"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Pfam" id="PF00057">
<property type="entry name" value="Ldl_recept_a"/>
<property type="match status" value="10"/>
</dbReference>
<dbReference type="Pfam" id="PF00058">
<property type="entry name" value="Ldl_recept_b"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF15902">
<property type="entry name" value="Sortilin-Vps10"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF15901">
<property type="entry name" value="Sortilin_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00261">
<property type="entry name" value="LDLRECEPTOR"/>
</dbReference>
<dbReference type="SMART" id="SM00060">
<property type="entry name" value="FN3"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00192">
<property type="entry name" value="LDLa"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="SMART" id="SM00135">
<property type="entry name" value="LY"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SMART" id="SM00602">
<property type="entry name" value="VPS10"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49265">
<property type="entry name" value="SSF49265"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57424">
<property type="entry name" value="SSF57424"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS01186">
<property type="entry name" value="EGF_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50853">
<property type="entry name" value="FN3"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS01209">
<property type="entry name" value="LDLRA_1"/>
<property type="match status" value="10"/>
</dbReference>
<dbReference type="PROSITE" id="PS50068">
<property type="entry name" value="LDLRA_2"/>
<property type="match status" value="11"/>
</dbReference>
<dbReference type="PROSITE" id="PS51120">
<property type="entry name" value="LDLRB"/>
<property type="match status" value="5"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0026">Alzheimer disease</keyword>
<keyword id="KW-1008">Amyloidosis</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0165">Cleavage on pair of basic residues</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0245">EGF-like domain</keyword>
<keyword id="KW-0254">Endocytosis</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<feature type="signal peptide" evidence="8">
<location>
<begin position="1"/>
<end position="28"/>
</location>
</feature>
<feature type="propeptide" description="Removed in mature form" id="PRO_0000033164" evidence="48">
<location>
<begin position="29"/>
<end position="81"/>
</location>
</feature>
<feature type="chain" description="Sortilin-related receptor" id="PRO_0000033165">
<location>
<begin position="82"/>
<end position="2214"/>
</location>
</feature>
<feature type="topological domain" description="Lumenal" evidence="8">
<location>
<begin position="82"/>
<end position="2137"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="8">
<location>
<begin position="2138"/>
<end position="2158"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="8">
<location>
<begin position="2159"/>
<end position="2214"/>
</location>
</feature>
<feature type="repeat" description="BNR 1">
<location>
<begin position="136"/>
<end position="147"/>
</location>
</feature>
<feature type="repeat" description="BNR 2">
<location>
<begin position="232"/>
<end position="243"/>
</location>
</feature>
<feature type="repeat" description="BNR 3">
<location>
<begin position="441"/>
<end position="452"/>
</location>
</feature>
<feature type="repeat" description="BNR 4">
<location>
<begin position="521"/>
<end position="532"/>
</location>
</feature>
<feature type="repeat" description="BNR 5">
<location>
<begin position="562"/>
<end position="573"/>
</location>
</feature>
<feature type="repeat" description="LDL-receptor class B 1">
<location>
<begin position="800"/>
<end position="843"/>
</location>
</feature>
<feature type="repeat" description="LDL-receptor class B 2">
<location>
<begin position="844"/>
<end position="887"/>
</location>
</feature>
<feature type="repeat" description="LDL-receptor class B 3">
<location>
<begin position="888"/>
<end position="932"/>
</location>
</feature>
<feature type="repeat" description="LDL-receptor class B 4">
<location>
<begin position="933"/>
<end position="970"/>
</location>
</feature>
<feature type="repeat" description="LDL-receptor class B 5">
<location>
<begin position="971"/>
<end position="1013"/>
</location>
</feature>
<feature type="domain" description="EGF-like">
<location>
<begin position="1026"/>
<end position="1072"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 1" evidence="9">
<location>
<begin position="1076"/>
<end position="1114"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 2" evidence="9">
<location>
<begin position="1115"/>
<end position="1155"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 3" evidence="9">
<location>
<begin position="1156"/>
<end position="1194"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 4" evidence="9">
<location>
<begin position="1198"/>
<end position="1236"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 5" evidence="9">
<location>
<begin position="1238"/>
<end position="1272"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 6" evidence="9">
<location>
<begin position="1273"/>
<end position="1317"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 7" evidence="9">
<location>
<begin position="1323"/>
<end position="1361"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 8" evidence="9">
<location>
<begin position="1366"/>
<end position="1405"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 9" evidence="9">
<location>
<begin position="1417"/>
<end position="1455"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 10" evidence="9">
<location>
<begin position="1469"/>
<end position="1508"/>
</location>
</feature>
<feature type="domain" description="LDL-receptor class A 11" evidence="9">
<location>
<begin position="1512"/>
<end position="1551"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 1" evidence="10">
<location>
<begin position="1557"/>
<end position="1649"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 2" evidence="10">
<location>
<begin position="1653"/>
<end position="1745"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 3" evidence="10">
<location>
<begin position="1749"/>
<end position="1844"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 4" evidence="10">
<location>
<begin position="1843"/>
<end position="1927"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 5" evidence="10">
<location>
<begin position="1934"/>
<end position="2029"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 6" evidence="10">
<location>
<begin position="2030"/>
<end position="2118"/>
</location>
</feature>
<feature type="region of interest" description="Required for efficient Golgi apparatus - endosome sorting" evidence="25">
<location>
<begin position="2190"/>
<end position="2214"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with GGA1 and GGA2" evidence="13">
<location>
<begin position="2201"/>
<end position="2214"/>
</location>
</feature>
<feature type="short sequence motif" description="Cell attachment site" evidence="8">
<location>
<begin position="63"/>
<end position="65"/>
</location>
</feature>
<feature type="short sequence motif" description="Potential nuclear localization signal for the C-terminal fragment generated by PSEN1" evidence="57">
<location>
<begin position="2161"/>
<end position="2164"/>
</location>
</feature>
<feature type="short sequence motif" description="Endocytosis signal" evidence="8">
<location>
<begin position="2172"/>
<end position="2177"/>
</location>
</feature>
<feature type="short sequence motif" description="DXXLL motif involved in the interaction with GGA1" evidence="30">
<location>
<begin position="2208"/>
<end position="2212"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="114"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by ROCK2" evidence="32">
<location>
<position position="2206"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="29">
<location>
<position position="99"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="158"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="368"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="430"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="616"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="674"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="818"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="871"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1035"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1068"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1164"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1191"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1246"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1367"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1458"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1608"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1706"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="29">
<location>
<position position="1733"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1809"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1854"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1894"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="1986"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="29">
<location>
<position position="2010"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="2054"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
<location>
<position position="2069"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="29">
<location>
<position position="2076"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="29">
<location>
<position position="2092"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1078"/>
<end position="1090"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1085"/>
<end position="1103"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1097"/>
<end position="1112"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1117"/>
<end position="1131"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1125"/>
<end position="1144"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1138"/>
<end position="1153"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1158"/>
<end position="1170"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1165"/>
<end position="1183"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1177"/>
<end position="1192"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1199"/>
<end position="1211"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1206"/>
<end position="1224"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1218"/>
<end position="1235"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1239"/>
<end position="1249"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1244"/>
<end position="1262"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1256"/>
<end position="1271"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1275"/>
<end position="1289"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1283"/>
<end position="1302"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1296"/>
<end position="1315"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1325"/>
<end position="1337"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1332"/>
<end position="1350"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1344"/>
<end position="1359"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1368"/>
<end position="1381"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1376"/>
<end position="1394"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1388"/>
<end position="1403"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1419"/>
<end position="1431"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1426"/>
<end position="1444"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1438"/>
<end position="1453"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1471"/>
<end position="1484"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1478"/>
<end position="1497"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1491"/>
<end position="1506"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1514"/>
<end position="1527"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1521"/>
<end position="1540"/>
</location>
</feature>
<feature type="disulfide bond" evidence="9">
<location>
<begin position="1534"/>
<end position="1549"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_036371" evidence="23">
<original>L</original>
<variation>S</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence variant" description="In AD; unknown pathological significance." id="VAR_070012" evidence="36">
<original>Y</original>
<variation>C</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="sequence variant" description="In AD; unknown pathological significance; loss of interaction with APP amyloid-beta peptides, hence reduced turnover of APP amyloid-beta peptides in cells." id="VAR_070013" evidence="36 41">
<original>G</original>
<variation>R</variation>
<location>
<position position="511"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2298813." id="VAR_020360" evidence="27">
<original>A</original>
<variation>T</variation>
<location>
<position position="528"/>
</location>
</feature>
<feature type="sequence variant" description="In AD; unknown pathological significance; dbSNP:rs377498269." id="VAR_070014" evidence="36">
<original>N</original>
<variation>S</variation>
<location>
<position position="924"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1699107." id="VAR_034508" evidence="18 48 49 50">
<original>Q</original>
<variation>E</variation>
<location>
<position position="1074"/>
</location>
</feature>
<feature type="sequence variant" description="In AD; unknown pathological significance; dbSNP:rs747306346." id="VAR_070015" evidence="36">
<original>N</original>
<variation>S</variation>
<location>
<position position="1358"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_036372" evidence="23">
<original>M</original>
<variation>L</variation>
<location>
<position position="1581"/>
</location>
</feature>
<feature type="sequence variant" description="In AD; unknown pathological significance; dbSNP:rs1565352546." id="VAR_070016" evidence="36">
<original>G</original>
<variation>D</variation>
<location>
<position position="1681"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1792120." id="VAR_034509" evidence="18 48 49 50">
<original>V</original>
<variation>I</variation>
<location>
<position position="1967"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation; dbSNP:rs766895956." id="VAR_036373" evidence="23">
<original>L</original>
<variation>V</variation>
<location>
<position position="1972"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of propeptide cleavage." evidence="12">
<original>RRKR</original>
<variation>GRKG</variation>
<location>
<begin position="78"/>
<end position="81"/>
</location>
</feature>
<feature type="mutagenesis site" description="Affects the nuclear location of the C-terminal fragment generated by PSEN1." evidence="22">
<original>RR</original>
<variation>AA</variation>
<location>
<begin position="2163"/>
<end position="2164"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on endocytosis." evidence="25">
<original>FANSHY</original>
<variation>AAASHA</variation>
<location>
<begin position="2172"/>
<end position="2177"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strong reduction in Golgi apparatus - endosome sorting. Loss of interaction with AP-1 complex." evidence="25">
<location>
<begin position="2190"/>
<end position="2214"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with GGA1 and PACS1. No effect on interaction with APP. Affects subcellular location, increasing localization at the cell surface, possibly due to drastically decreased endocytosis. Impaired Golgi apparatus - endosome sorting. Increased amyloidogenic APP processing by beta-secretase, resulting in increased levels of soluble APP-beta and amyloid-beta protein 40 and 42. Loss of APOA5 internalization." evidence="25 26 28">
<original>DDLGEDDED</original>
<variation>AALGAAAAA</variation>
<location>
<begin position="2190"/>
<end position="2198"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the interaction with HSPA12A." evidence="46">
<original>DD</original>
<variation>AA</variation>
<location>
<begin position="2190"/>
<end position="2191"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strong decrease in interaction with HSPA12A." evidence="46">
<original>EDDED</original>
<variation>AAAAA</variation>
<location>
<begin position="2194"/>
<end position="2198"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on endocytosis. Decreased Golgi apparatus - endosome sorting." evidence="25">
<original>MI</original>
<variation>AA</variation>
<location>
<begin position="2201"/>
<end position="2202"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the interaction with HSPA12A." evidence="46">
<original>TG</original>
<variation>AA</variation>
<location>
<begin position="2203"/>
<end position="2204"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the interaction with HSPA12A." evidence="46">
<original>FS</original>
<variation>AA</variation>
<location>
<begin position="2205"/>
<end position="2206"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strong decrease in interaction with HSPA12A." evidence="46">
<original>DD</original>
<variation>AA</variation>
<location>
<begin position="2207"/>
<end position="2208"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with GGA1 and PACS1. No effect on interaction with APP. Affects subcellular location, by causing increased localization to recycling endosomes. Increased APP processing by alpha-secretase, resulting in increased levels of soluble APP-alpha and C83 APP fragments. Decreased APP processing by beta-secretase, resulting in reduced levels of C99 APP fragment." evidence="26">
<original>DVPM</original>
<variation>AVPA</variation>
<location>
<begin position="2208"/>
<end position="2211"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on the interaction with HSPA12A." evidence="46">
<original>VP</original>
<variation>AA</variation>
<location>
<begin position="2209"/>
<end position="2210"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on endocytosis. Affects LPL sorting to endosomes." evidence="25 34">
<location>
<begin position="2211"/>
<end position="2214"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="48"/>
<end position="51"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="91"/>
<end position="98"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="103"/>
<end position="109"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="117"/>
<end position="122"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="125"/>
<end position="128"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="133"/>
<end position="140"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="145"/>
<end position="147"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="149"/>
<end position="151"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="164"/>
<end position="169"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="177"/>
<end position="192"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="198"/>
<end position="201"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="207"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="219"/>
<end position="223"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="230"/>
<end position="236"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="242"/>
<end position="253"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="256"/>
<end position="258"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="264"/>
<end position="268"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="271"/>
<end position="273"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="275"/>
<end position="282"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="287"/>
<end position="289"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="290"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="300"/>
<end position="303"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="306"/>
<end position="313"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="318"/>
<end position="320"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="323"/>
<end position="330"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="333"/>
<end position="337"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="349"/>
<end position="353"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="355"/>
<end position="358"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="360"/>
<end position="363"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="366"/>
<end position="368"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="369"/>
<end position="374"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="383"/>
<end position="391"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="394"/>
<end position="396"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="397"/>
<end position="400"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="402"/>
<end position="405"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="411"/>
<end position="416"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="420"/>
<end position="422"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="424"/>
<end position="428"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="431"/>
<end position="434"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="435"/>
<end position="437"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="439"/>
<end position="445"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="451"/>
<end position="453"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="460"/>
<end position="462"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="469"/>
<end position="471"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="473"/>
<end position="479"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="480"/>
<end position="485"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="492"/>
<end position="495"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="504"/>
<end position="510"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="519"/>
<end position="525"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="531"/>
<end position="536"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="538"/>
<end position="543"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="544"/>
<end position="546"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="548"/>
<end position="553"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="560"/>
<end position="566"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="572"/>
<end position="575"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="577"/>
<end position="579"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="581"/>
<end position="588"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="596"/>
<end position="602"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="604"/>
<end position="607"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="610"/>
<end position="616"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="618"/>
<end position="621"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="627"/>
<end position="629"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="630"/>
<end position="633"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="635"/>
<end position="637"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="638"/>
<end position="641"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="647"/>
<end position="654"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="670"/>
<end position="674"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="679"/>
<end position="681"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="682"/>
<end position="684"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="688"/>
<end position="690"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="694"/>
<end position="696"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="699"/>
<end position="701"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="703"/>
<end position="705"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="722"/>
<end position="724"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="727"/>
<end position="730"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="740"/>
<end position="745"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="748"/>
<end position="750"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1655"/>
<end position="1660"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1669"/>
<end position="1674"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1683"/>
<end position="1692"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1699"/>
<end position="1710"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1718"/>
<end position="1729"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1731"/>
<end position="1734"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1738"/>
<end position="1741"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2DM4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WSX"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WSY"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WSZ"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O88307"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q95209"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255"/>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00124"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00316"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11082041"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11294867"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11821067"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12530537"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14764453"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15053742"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15364913"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16174740"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16393139"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16407538"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16531402"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17326667"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17646382"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17855360"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18407551"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18603531"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20015111"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20385770"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21147781"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21220680"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21385844"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21994944"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22472873"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23333276"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23486467"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23565137"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23977241"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24523320"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26858303"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27322061"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28265003"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30448281"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30679749"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31138794"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8940146"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9157966"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14764453"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16531402"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8940146"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000305"/>
<evidence key="55" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11082041"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11294867"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16531402"/>
</source>
</evidence>
<sequence length="2214" mass="248426" checksum="4C215BB33E65C0B2" modified="2010-05-18" version="2" precursor="true">MATRSSRRESRLPFLFTLVALLPPGALCEVWTQRLHGGSAPLPQDRGFLVVQGDPRELRLWARGDARGASRADEKPLRRKRSAALQPEPIKVYGQVSLNDSHNQMVVHWAGEKSNVIVALARDSLALARPKSSDVYVSYDYGKSFKKISDKLNFGLGNRSEAVIAQFYHSPADNKRYIFADAYAQYLWITFDFCNTLQGFSIPFRAADLLLHSKASNLLLGFDRSHPNKQLWKSDDFGQTWIMIQEHVKSFSWGIDPYDKPNTIYIERHEPSGYSTVFRSTDFFQSRENQEVILEEVRDFQLRDKYMFATKVVHLLGSEQQSSVQLWVSFGRKPMRAAQFVTRHPINEYYIADASEDQVFVCVSHSNNRTNLYISEAEGLKFSLSLENVLYYSPGGAGSDTLVRYFANEPFADFHRVEGLQGVYIATLINGSMNEENMRSVITFDKGGTWEFLQAPAFTGYGEKINCELSQGCSLHLAQRLSQLLNLQLRRMPILSKESAPGLIIATGSVGKNLASKTNVYISSSAGARWREALPGPHYYTWGDHGGIITAIAQGMETNELKYSTNEGETWKTFIFSEKPVFVYGLLTEPGEKSTVFTIFGSNKENVHSWLILQVNATDALGVPCTENDYKLWSPSDERGNECLLGHKTVFKRRTPHATCFNGEDFDRPVVVSNCSCTREDYECDFGFKMSEDLSLEVCVPDPEFSGKSYSPPVPCPVGSTYRRTRGYRKISGDTCSGGDVEARLEGELVPCPLAEENEFILYAVRKSIYRYDLASGATEQLPLTGLRAAVALDFDYEHNCLYWSDLALDVIQRLCLNGSTGQEVIINSGLETVEALAFEPLSQLLYWVDAGFKKIEVANPDGDFRLTIVNSSVLDRPRALVLVPQEGVMFWTDWGDLKPGIYRSNMDGSAAYHLVSEDVKWPNGISVDDQWIYWTDAYLECIERITFSGQQRSVILDNLPHPYAIAVFKNEIYWDDWSQLSIFRASKYSGSQMEILANQLTGLMDMKIFYKGKNTGSNACVPRPCSLLCLPKANNSRSCRCPEDVSSSVLPSGDLMCDCPQGYQLKNNTCVKQENTCLRNQYRCSNGNCINSIWWCDFDNDCGDMSDERNCPTTICDLDTQFRCQESGTCIPLSYKCDLEDDCGDNSDESHCEMHQCRSDEYNCSSGMCIRSSWVCDGDNDCRDWSDEANCTAIYHTCEASNFQCRNGHCIPQRWACDGDTDCQDGSDEDPVNCEKKCNGFRCPNGTCIPSSKHCDGLRDCSDGSDEQHCEPLCTHFMDFVCKNRQQCLFHSMVCDGIIQCRDGSDEDAAFAGCSQDPEFHKVCDEFGFQCQNGVCISLIWKCDGMDDCGDYSDEANCENPTEAPNCSRYFQFRCENGHCIPNRWKCDRENDCGDWSDEKDCGDSHILPFSTPGPSTCLPNYYRCSSGTCVMDTWVCDGYRDCADGSDEEACPLLANVTAASTPTQLGRCDRFEFECHQPKTCIPNWKRCDGHQDCQDGRDEANCPTHSTLTCMSREFQCEDGEACIVLSERCDGFLDCSDESDEKACSDELTVYKVQNLQWTADFSGDVTLTWMRPKKMPSASCVYNVYYRVVGESIWKTLETHSNKTNTVLKVLKPDTTYQVKVQVQCLSKAHNTNDFVTLRTPEGLPDAPRNLQLSLPREAEGVIVGHWAPPIHTHGLIREYIVEYSRSGSKMWASQRAASNFTEIKNLLVNTLYTVRVAAVTSRGIGNWSDSKSITTIKGKVIPPPDIHIDSYGENYLSFTLTMESDIKVNGYVVNLFWAFDTHKQERRTLNFRGSILSHKVGNLTAHTSYEISAWAKTDLGDSPLAFEHVMTRGVRPPAPSLKAKAINQTAVECTWTGPRNVVYGIFYATSFLDLYRNPKSLTTSLHNKTVIVSKDEQYLFLVRVVVPYQGPSSDYVVVKMIPDSRLPPRHLHVVHTGKTSVVIKWESPYDSPDQDLLYAVAVKDLIRKTDRSYKVKSRNSTVEYTLNKLEPGGKYHIIVQLGNMSKDSSIKITTVSLSAPDALKIITENDHVLLFWKSLALKEKHFNESRGYEIHMFDSAMNITAYLGNTTDNFFKISNLKMGHNYTFTVQARCLFGNQICGEPAILLYDELGSGADASATQAARSTDVAAVVVPILFLILLSLGVGFAILYTKHRRLQSSFTAFANSHYSSRLGSAIFSSGDDLGEDDEDAPMITGFSDDVPMVIA</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

